Skip to main content
Premium Trial:

Request an Annual Quote

Stratos Genomics Raises $2.1M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Stratos Genomics today said that it has raised $2.1 million in a private financing from existing investors in the firm.

The privately-held Seattle-based firm is developing an ultra-low-cost nucleic acid sequencing technology for whole-genome analysis and molecular diagnostic applications. The firm, which is a spinoff of Stratos Group, has developed a single-molecule sequencing method called "sequencing by expansion."

The funds raised today are in addition to its August 2010 Series A round, which raised $4 million. Investors in that round included Stratos Group and Fisk Ventures.

"Our shareholders recognize that we are entering an exciting phase and don't want our validation pace interrupted by external fundraising activities," Stratos Genomics CEO Allan Stephan said in a statement.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.